These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 215374)

  • 1. Long-term treatment of hypertension in man by an orally active angiotensin-converting enzyme inhibitor.
    Brunner HR; Gavras H; Turini GA; Waeber B; Cappuis P; McKinstry DN
    Clin Sci Mol Med Suppl; 1978 Dec; 4():293s-295s. PubMed ID: 215374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic treatment of hypertension by an inhibitor of angiotensin converting enzyme].
    Waeber B; Gavras H; Brunner HR; Chappuis P; Turini GA
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1981-3. PubMed ID: 219469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement by diuretics of the antihypertensive action of long-term angiotensin converting enzyme blockade.
    Brunner HR; Gavras H; Waeber B
    Clin Exp Hypertens (1978); 1980; 2(3-4):639-57. PubMed ID: 6253243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients.
    Brunner HR; Gavras H; Waeber B; Kershaw GR; Turini GA; Vukovich RA; McKinstry DN; Gavras I
    Ann Intern Med; 1979 Jan; 90(1):19-23. PubMed ID: 217289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension.
    Brunner HR; Gavras H; Waeber B; Turini GA; McKinstry DN; Vukovich RA; Gavras I
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):205S-211S. PubMed ID: 223614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
    Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
    Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
    Havelka J; Vetter H; Studer A; Greminger P; Lüscher T; Wollnik S; Siegenthaler W; Vetter W
    Am J Cardiol; 1982 Apr; 49(6):1467-74. PubMed ID: 6280477
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
    Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
    Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
    Ueda Y; Honda M; Hatano M
    Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
    Chan PS; Ronsberg MA; Cervoni P
    Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effect of the oral angiotensin I-converting enzyme inhibitor in long-term treatment of hypertensive patients.
    Mizuno K; Gotoh M; Matsui J; Fukuchi S
    Jpn Heart J; 1981 Nov; 22(6):903-13. PubMed ID: 7040724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
    Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y
    Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A screening test for renovascular hypertension by means of orally active angiotensin I converting enzyme inhibitor, captopril (SQ 14225).
    Imai Y; Abe K; Otsuka Y; Sakurai Y; Yoshinaga K
    Tohoku J Exp Med; 1980 Jul; 131(3):311-2. PubMed ID: 6998048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure.
    Brunner HR; Waeber B; Wauters JP; Turin G; McKinstry D; Gavras H
    Lancet; 1978 Sep; 2(8092 Pt 1):704-7. PubMed ID: 80634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.
    Sullivan JM; Ginsburg BA; Ratts TE; Johnson JG; Barton BR; Kraus DH; McKinstry DN; Muirhead EE
    Hypertension; 1979; 1(4):397-401. PubMed ID: 232084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
    Waeber B; Gavras I; Brunner HR; Cook CA; Charocopos F; Gavras HP
    Am Heart J; 1982 Mar; 103(3):384-90. PubMed ID: 6278905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.